GlassScriptPhysician profile
Kevin Kleis
NPI 1649566456
$25,643.76
in general payments reported to CMS, 2019-2025
29 companies · $1,923 in 2025
The $1,923 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $2,941 · 2021: $7,569 · 2022: $2,284 · 2023: $9,001 · 2024: $1,138 · 2025: $1,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,402 · Food and Beverage: $4,741 · Travel and Lodging: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,402.13 |
| Food and Beverage | $4,740.58 |
| Travel and Lodging | $1,920.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $10,022.54 | 2021-2024 | Velys |
| Zimmer Biomet Holdings, INC. | $4,918.69 | 2019-2025 | Hammr Curved G7 Impactor, Persona, Z1 Hip System |
| Prodigy Surgical Distribution, INC. | $3,420.60 | 2020-2023 | |
| Depuy Synthes Sales INC. | $1,820.63 | 2019-2025 | Velys, Attune, Actis |
| Stryker Corporation | $1,675.87 | 2019-2025 | Mako, Gamma |
| Smith+Nephew, INC. | $694.05 | 2019-2023 | Trigen, Evos Mini, Spatial Frame |
| Arthrex, INC. | $643.08 | 2021-2023 | |
| Linvatec Corporation | $482.88 | 2022-2025 | Biobrace 23mm |
| Medacta USA, INC. | $286.63 | 2021-2023 | Gmk Sphere |
| Ferring Pharmaceuticals INC. | $259.27 | 2020-2025 | Euflexxa |
| Medtronic, INC. | $248.21 | 2025 | Aquamantys(Tm) |
| Maxx Orthopedics, INC. | $230.74 | 2022-2024 | |
| Anika Therapeutics, INC. | $124.75 | 2022 | |
| Avanos Medical | $120.00 | 2019 | |
| Biocomposites INC | $115.99 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $110.07 | 2023-2024 | Zilretta, Iovera, Exparel |
| Kowa Pharmaceuticals America, INC. | $74.11 | 2023 | Seglentis |
| Heraeus Medical, LLC. | $66.34 | 2020-2025 | Palacos |
| Vertex Pharmaceuticals Incorporated | $61.42 | 2024-2025 | |
| Bioventus LLC | $54.14 | 2019-2022 | |
| Pacira Therapeutics, INC. | $40.28 | 2019 | |
| Organogenesis INC. | $39.96 | 2021 | |
| Becton, Dickinson and Company | $34.41 | 2025 | Arista |
| Aesculap, INC. | $19.15 | 2024 | Cranioplate |
| Novo Nordisk INC | $17.88 | 2023 | Wegovy |
| Wright Medical Technology, INC. | $17.32 | 2019 | |
| Orthalign INC | $15.18 | 2024 | Orthalign Plus |
| Ethicon US, LLC | $14.83 | 2021 | |
| Ermi LLC | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kleis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.